SCHEMBL24045384

SCHEMBL24045384

OC(O)C(F)(F)c1cc2ccccc2o1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 2/20 0.42
FLT3 P36888 1/20 0.42
MGLL Q99685 1/20 0.42
HSD17B10 Q99714 1/20 0.42
TDP1 Q9NUW8 1/20 0.42
CYP19A1 P11511 2/20 0.41
TYR P14679 1/20 0.41
DAO P14920 1/20 0.41
AKR1B1 P15121 1/20 0.41
HPGD P15428 1/20 0.41
NPC1 O15118 3/20 0.38
RAB9A P51151 2/20 0.38
NFKB1 P19838 1/20 0.38
NFKB2 Q00653 1/20 0.38
RELA Q04206 1/20 0.38
MAOB P27338 3/20 0.38
CYP2A6 P11509 2/20 0.38
LOXL2 Q9Y4K0 1/20 0.38
CYP2D6 P10635 1/20 0.38
HIF1A Q16665 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL676612 0.79 KDM4E (0.45) KDM4EFLT3MGLLHSD17B10TDP1
SCHEMBL20799425 0.78 MAOB (0.44) KDM4EHSD17B10NPC1RAB9AMAOB
SCHEMBL16595609 0.74 FLT3 (0.49) KDM4EFLT3TYRDAOAKR1B1
SCHEMBL2424372 0.73 CYP2D6 (0.45) KDM4EFLT3MGLLHSD17B10TDP1
SCHEMBL8036000 0.72 KDM4E (0.46) KDM4EFLT3MGLLHSD17B10TDP1
SCHEMBL28750544 0.71 MAPT (0.45) KDM4EFLT3MGLLHSD17B10TDP1
SCHEMBL800706 0.71 KDM4E (0.44) KDM4EFLT3MGLLHSD17B10TDP1
SCHEMBL28018770 0.70 KDM4E (0.44) KDM4EFLT3MGLLHSD17B10TDP1
SCHEMBL23692162 0.68 MAOB (0.43) KDM4EFLT3MGLLHSD17B10TDP1
SCHEMBL5776749 0.68 FLT3 (0.46) KDM4EFLT3MGLLHSD17B10TDP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3912977-A1 GLUCOSYLCERAMIDE SYNTHASE INHIBITORS FOR THE TREATMENT OF DISEASES BioMarin Pharmaceutical Inc. (US) 2021-11-24 EP disclosed